Citadel Advisors’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.09M | Buy |
56,900
+15,900
| +39% | +$313K | ﹤0.01% | 7457 |
|
|
2025
Q4 | $777K | Buy |
41,000
+12,000
| +41% | +$222K | ﹤0.01% | 7982 |
|
|
2025
Q3 | $541K | Sell |
29,000
-17,700
| -38% | -$331K | ﹤0.01% | 8945 |
|
|
2025
Q2 | $861K | Buy |
46,700
+19,100
| +69% | +$339K | ﹤0.01% | 7425 |
|
|
2025
Q1 | $482K | Buy |
27,600
+1,700
| +7% | +$28.7K | ﹤0.01% | 8550 |
|
|
2024
Q4 | $449K | Sell |
25,900
-15,800
| -38% | -$288K | ﹤0.01% | 8807 |
|
|
2024
Q3 | $776K | Buy |
41,700
+1,100
| +3% | +$18.5K | ﹤0.01% | 7351 |
|
|
2024
Q2 | $625K | Sell |
40,600
-71,800
| -64% | -$1.03M | ﹤0.01% | 7588 |
|
|
2024
Q1 | $1.66M | Buy |
112,400
+54,200
| +93% | +$750K | ﹤0.01% | 5890 |
|
|
2023
Q4 | $831K | Sell |
58,200
-25,200
| -30% | -$358K | ﹤0.01% | 7052 |
|
|
2023
Q3 | $1.16M | Buy |
83,400
+23,600
| +39% | +$302K | ﹤0.01% | 6258 |
|
|
2023
Q2 | $704K | Sell |
59,800
-3,100
| -5% | -$35.3K | ﹤0.01% | 7188 |
|
|
2023
Q1 | $723K | Buy |
62,900
+23,600
| +60% | +$292K | ﹤0.01% | 7484 |
|
|
2022
Q4 | $488K | Buy |
39,300
+9,500
| +32% | +$121K | ﹤0.01% | 8293 |
|
|
2022
Q3 | $391K | Sell |
29,800
-11,700
| -28% | -$173K | ﹤0.01% | 8996 |
|
|
2022
Q2 | $580K | Sell |
41,500
-19,100
| -32% | -$255K | ﹤0.01% | 8306 |
|
|
2022
Q1 | $902K | Sell |
60,600
-500
| -0.8% | -$6.84K | ﹤0.01% | 7949 |
|
|
2021
Q4 | $827K | Sell |
61,100
-1,400
| -2% | -$19.8K | ﹤0.01% | 8405 |
|
|
2021
Q3 | $920K | Buy |
62,500
+17,100
| +38% | +$289K | ﹤0.01% | 8366 |
|
|
2021
Q2 | $826K | Buy |
45,400
+12,900
| +40% | +$230K | ﹤0.01% | 8860 |
|
|
2021
Q1 | $564K | Buy |
32,500
+5,700
| +21% | +$100K | ﹤0.01% | 9414 |
|
|
2020
Q4 | $466K | Sell |
26,800
-27,700
| -51% | -$442K | ﹤0.01% | 8271 |
|
|
2020
Q3 | $751K | Buy |
54,500
+2,300
| +4% | +$33.8K | ﹤0.01% | 6561 |
|
|
2020
Q2 | $753K | Sell |
52,200
-25,800
| -33% | -$339K | ﹤0.01% | 6350 |
|
|
2020
Q1 | $852K | Buy |
78,000
+35,700
| +84% | +$658K | ﹤0.01% | 5612 |
|
|
2019
Q4 | $903K | Sell |
42,300
-4,100
| -9% | -$91.8K | ﹤0.01% | 5787 |
|
|
2019
Q3 | $1.06M | Buy |
46,400
+4,200
| +10% | +$89.6K | ﹤0.01% | 5493 |
|
|
2019
Q2 | $831K | Buy |
42,200
+15,100
| +56% | +$294K | ﹤0.01% | 6001 |
|
|
2019
Q1 | $528K | Sell |
27,100
-22,400
| -45% | -$424K | ﹤0.01% | 6703 |
|
|
2018
Q4 | $816K | Buy |
49,500
+18,800
| +61% | +$378K | ﹤0.01% | 5607 |
|
|
2018
Q3 | $710K | Buy |
30,700
+15,900
| +107% | +$360K | ﹤0.01% | 6137 |
|
|
2018
Q2 | $322K | Buy |
+14,800
| New | +$289K | ﹤0.01% | 7094 |
|
Other funds holding SBRA
VPM
VCM
N
Citadel Advisors's SBRA Position: Q1 2026 in Review
Citadel Advisors increased its Sabra Healthcare REIT (SBRA) stake by 382% in Q1 2026, buying an estimated $9.79M and bringing the position to 627,374 shares worth $12.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2995.
Citadel Advisors first reported a position in SBRA in Q4 2013 and has held it in 45 quarters since. The position peaked at $71.8M in Q4 2017. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.
- Citadel Advisors held 627,374 shares of Sabra Healthcare REIT worth $12.1M as of Q1 2026.
- Citadel Advisors bought 497,259 Sabra Healthcare REIT shares in Q1 2026, an estimated $9.79M.
- Sabra Healthcare REIT made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2995 holding.
- Citadel Advisors first reported a position in Sabra Healthcare REIT in Q4 2013 and has held it in 45 quarters since.
- Citadel Advisors's Sabra Healthcare REIT position peaked at $71.8M in Q4 2017.
- 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.